$11.32
Today
as of Sep 4, 16:51 ET
Last 30 days
Recent Press Releases & News
Why Is Keros Therapeutics (KROS) Up 8% Since Last Earnings Report?
KROS $20M Takeda Milestone Adds Cash but Revenue Visibility Stays Weak
Should You Buy KROS Stock as Pipeline Promise Meets Revenue Risk?
Overview
52-week range
$9.69
$23
13% of range
Avg surprise (last 3)
+12,101%
Avg reaction (last 2)
-6.9%
0% positive
Latest IV / EM
181%
EM ±28.3% · $13 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-1.45 | — | — | — | — | financials |
| Thu May 14, 2026 | Mar/2026 | $-1.21 | $-0.92 | -31.5% | -133.4% | -8.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.18 | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | $-0.76 | $-1.14 | +33.3% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $3.62 | $-0.01 | +36,300% | — | -5.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-1.41 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-1.25 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.21 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.33 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-1.27 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-1.26 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $32,000 | — | $14M | $18M | $211M | — | $0 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-31M | $-26M | — | $-15M | $-40M | $152M | — | $-59M |
| Net income | $-29M | $-24M | — | $-7M | $-31M | $148M | — | $-53M |
| EPS (diluted) | $-1.45 | $-1.21 | — | $-0.18 | $-0.76 | $3.62 | — | $-1.41 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $258M | $281M | $287M | $693M | $690M | $721M | $560M | $531M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $267M | $291M | $315M | $719M | $733M | $760M | $589M | $552M |
| Total assets | $288M | $312M | $338M | $743M | $757M | $785M | $616M | $579M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $25M | $27M | $35M | $39M | $50M | $56M | $44M | $46M |
| Total equity | $262M | $286M | $303M | $704M | $707M | $729M | $572M | $533M |